Your session is about to expire
← Back to Search
Behavioral Intervention
Cancer Screening Methods for Colorectal and Liver Cancer (GTI Trial)
N/A
Waitlist Available
Led By Shari S Rogal, MD, MPH
Research Sponsored by University of Pittsburgh
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Providers: ≥18 years of age
Be older than 18 years old
Must not have
Veterans: <18 years of age
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, month 1, month 2, month 3, month 4, month 5, month 6, month 7, month 8, month 9, month 10, month 11, month 12
Awards & highlights
No Placebo-Only Group
Summary
"This trial aims to compare two methods of increasing cancer testing rates for gastrointestinal cancers like colon and liver cancer. The study will look at whether it is more effective to directly reach out to people who need testing
Who is the study for?
This trial is for veterans who may be at risk of gastrointestinal cancers, such as colon or liver cancer. It's designed to find better ways to increase cancer screening rates among this group.
What is being tested?
The study compares two methods to boost cancer screenings: direct outreach to patients and support for providers to overcome barriers in the testing process. The effectiveness will be measured by changes in screening rates.
What are the potential side effects?
Since this trial focuses on improving screening processes rather than testing new medications, there are no direct side effects from interventions like drugs. However, participants might experience inconvenience or anxiety related to increased engagement with healthcare services.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am 18 years old or older.
Exclusion Criteria
You may be eligible for the trial if you check “No” for criteria below:Select...
I am a veteran and under 18 years old.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ baseline, month 1, month 2, month 3, month 4, month 5, month 6, month 7, month 8, month 9, month 10, month 11, month 12
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, month 1, month 2, month 3, month 4, month 5, month 6, month 7, month 8, month 9, month 10, month 11, month 12
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Change in Reach of CRC screening from Baseline to 12 months
Change in Reach of HCC screening from Baseline to 12 months
Secondary study objectives
Acceptability assessed by the Acceptability of Intervention Measure (AIM)
Appropriateness assessed by the Intervention Appropriateness Measure (IAM)
Change in Adoption of screening from Baseline to 12 months
+6 moreAwards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Active Control
Group I: Patient Navigation (PN)Active Control1 Intervention
Half of the HCC sites and half of the CRC sites will be randomized to PN delivered by Clinical Resource Hub navigators.
Group II: Implementation Facilitation (IF)Active Control1 Intervention
Half of the HCC sites and half of the CRC sites will be randomized to IF delivered by 2 facilitators (one clinical and one evaluation expert) per site.
Find a Location
Who is running the clinical trial?
University of PittsburghLead Sponsor
1,776 Previous Clinical Trials
16,323,100 Total Patients Enrolled
2 Trials studying Liver Cancer
145 Patients Enrolled for Liver Cancer
Patient-Centered Outcomes Research InstituteOTHER
572 Previous Clinical Trials
27,047,301 Total Patients Enrolled
Shari S Rogal, MD, MPHPrincipal InvestigatorUniversity of Pittsburgh
1 Previous Clinical Trials
30 Total Patients Enrolled
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger